Obesity
Obesity is a growing pandemic that is driving the current public health crises worldwide.
In Mexico, during the 1990s, the estimated prevalence of obesity in the population was around 15%. Today, it is calculated that approximately 36.5% of adults live with obesity, with a higher prevalence in women than in men.
Our culture and current habits significantly contribute to the increase in these numbers. Modern lifestyles, work dynamics, and the high availability of highly processed foods have triggered a series of factors that progressively deteriorate our health.
People living with obesity face medium- and long-term consequences, not only in their physical appearance but also in their functional, emotional, and social well-being. Among the main associated diseases are diabetes mellitus, dyslipidemia (elevated blood lipids), high blood pressure, heart ischemia, heart attacks, and sudden death.
Additionally, it is increasingly common to see patients with obesity experience a significant loss of functionality and mobility, often becoming dependent on wheelchairs, electric mobility devices, and even becoming bedridden.
How Can I Know My Body Mass Index (BMI)?
Body Mass Index (BMI) Calculator
Medication-Based Treatment:
At Metaboli-K, medical treatment represents an effective option for weight management and improvement of metabolic conditions, depending on each patient's individual profile.
- Weekly injectable Semaglutide (Ozempic)
- Daily oral Semaglutide (Rybelsus)
- High-dose weekly injectable Semaglutide (Wegovy)
- New weekly injectable Tirzepatide (Mounjaro)
- Daily injectable Liraglutide (Saxenda)
Bariatric Surgery:
In some cases, the Metaboli-K team may recommend surgical interventions as part of the treatment plan. There will be situations where the initial approach is medical, but the definitive treatment is carried out through surgical intervention.
- Gastric Sleeve Single-Anastomosis
- Gastric Bypass
- Gastric Bypass
Dr. Moisés Arturo Hernández Loreto
Metaboli-K Department – Grupo Cardiovascular Tijuana
Dr. Moisés Hernández is a graduate of the Tijuana School of Medicine at the Autonomous University of Baja California (UABC). He completed his internship studies in Houston, Texas, USA, and for the past 17 years has been a leader in clinical research in San Diego, California, with a specialized focus on metabolic diseases such as diabetes, obesity, fatty liver, and steatohepatitis.
Throughout his extensive career in the research industry, Dr. Hernández has gained in-depth knowledge of current and emerging therapies, as well as the most advanced molecules and technologies for the treatment of metabolic diseases, participating in more than 300 research protocols.
Dr. Hernández has been a member of the American Diabetes Association since 2014 and actively participates in multiple international forums dedicated to the treatment of metabolic diseases.
